Ignite Creation Date:
2024-07-17 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492317
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-30
Brief Title:
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Organization Data
Organization:
The First Affiliated Hospital of Zhengzhou University
Class:
OTHER
Study ID:
S2021-K006-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Lead Sponsor Class:
OTHER
Responsible Party:
Yongxu Jia
Responsible Party Title:
Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital of Zhengzhou University
Old Name:
None
Old Organization:
None